Thyrocare Technologies Announcements
Please find attached herewith Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026
06 Apr, 2026 | 07:56pm • Source: BSE
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 31, 2026 for...
01 Apr, 2026 | 10:12am • Source: BSE
Please find enclosed herewith Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure) Regulations, 2015
29 Mar, 2026 | 08:37pm • Source: BSE
Please find attached the Intimation for Closure of Trading Window
23 Mar, 2026 | 03:51pm • Source: BSE
Allotment of 3,624 equity shares under Thyrocare Employee Stock Option Scheme of the Company
02 Mar, 2026 | 03:21pm • Source: BSE
Please find attached herewith Transcript of Earnings Call held on January 28, 2026
02 Feb, 2026 | 05:07pm • Source: BSE
Please find attached the Newspaper Publications on Unaudited Financial results for the quarter and nine months ended on December 31, 2025
29 Jan, 2026 | 12:12pm • Source: BSE
Please find attached herewith Intimation of receipt of Awards.
22 Jan, 2026 | 09:33pm • Source: BSE
We wish to intimate that a conference call for the analysts/ investors is arranged by our management to discuss the Company''s Unaudited Financial Results for...
20 Jan, 2026 | 04:16pm • Source: BSE
Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and...
20 Jan, 2026 | 03:21pm • Source: BSE
Please find attached herewith intimation regarding change of name of M S K A & Associates, Chartered Accountants to M S K A & Associates...
17 Jan, 2026 | 09:36pm • Source: BSE
Please find attached herewith Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025
08 Jan, 2026 | 06:04pm • Source: BSE
Thyrocare Technologies Limited has informed the Exchange regarding Appointment of Mr. Rajdeep Panwar as Chief Commercial Officer of the company w.e.f. January 05, 2026
05 Jan, 2026 | 01:36pm • Source: NSE
Appointment of Mr. Rajdeep Panwar as Chief Commercial Officer of the Company.
05 Jan, 2026 | 11:12am • Source: BSE
Thyrocare Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
23 Dec, 2025 | 12:03pm • Source: NSE
Please find attached herewith the Intimation for Closure of Trading Window
23 Dec, 2025 | 11:50am • Source: BSE
Thyrocare Technologies Limited has informed the Exchange regarding Appointment of Dr. Ramesh Kinha as Chief Operating Officer of the Company w.e.f. December 18, 2025
18 Dec, 2025 | 11:25am • Source: NSE
Thyrocare Technologies Limited has informed the Exchange about the Appointment of Dr. Ramesh Kinha as Chief Operating Officer (COO) of the Company
18 Dec, 2025 | 11:24am • Source: NSE
Appointment of Dr. Ramesh Kinha as Chief Operating Officer (COO) of the Company
18 Dec, 2025 | 10:42am • Source: BSE